Document Detail


Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.
MedLine Citation:
PMID:  19346873     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The first annual conference on immunotherapy in pediatric oncology was held in Bethesda, MD, from September 9 to 10, 2008 to discuss the state-of-the-art of immunotherapeutic strategies currently being explored in pediatric oncology. Major topics included targeting cell surface receptors, understanding and improving T-cell-based therapies, augmenting innate immune strategies, and enhancing graft-versus-leukemia for pediatric malignancies. As can be seen in the summaries of the individual presentations, significant progress has been made in developing preclinical models of pediatric tumors and a variety of novel immunobiologic therapies are approaching, or already in, the clinic. Although there is much excitement about the potential utility of these agents, a great deal of challenges lie ahead in improving the efficacy of each of these modalities and getting them to patients in a timely fashion. The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies.
Authors:
Christian M Capitini; Laurence J N Cooper; R Maarten Egeler; Rupert Handgretinger; Franco Locatelli; Paul M Sondel; Crystal L Mackall
Related Documents :
22144083 - Ethics in the practice of speech-language pathology in health care settings.
7574133 - Recommended guidelines for uniform reporting of pediatric advanced life support: the pe...
3370373 - The usefulness of monographic proceedings.
Publication Detail:
Type:  Congresses; Research Support, N.I.H., Intramural    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  31     ISSN:  1536-3678     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-06     Completed Date:  2009-04-29     Revised Date:  2012-03-08    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  227-44     Citation Subset:  IM    
Affiliation:
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA. capitinic@mail.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Humans
Immunotherapy / trends*
Internationality
Medical Oncology
Neoplasms / immunology*,  therapy*
Pediatrics
Grant Support
ID/Acronym/Agency:
Z01 SC010281-10/SC/NCI NIH HHS; Z01 SC010289-09/SC/NCI NIH HHS; Z99 CA999999/CA/NCI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased risk of general anesthesia for high-risk patients undergoing magnetic resonance imaging.
Next Document:  Her-2/neu, p-53, and their coexpression in osteosarcoma.